T-Day 5mg is primarily indicated in conditions like Chronic urticaria, NSAID associated ulceration, Rhinitis, To prevent recurrence of neural tube defect.
T-Day 5mg is contraindicated in conditions like Porphyria, Adjunct in treatment of opioid dependance.
T-Day 5mg produces potentially life-threatening effects which include Agranulocytosis, Thrombocytopenia, Pancytopenia, Paresthesia. which are responsible for the discontinuation of T-Day 5mg therapy. The symptomatic adverse reactions produced by T-Day 5mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Nausea, Dyspnea, Confusion, Sleep disturbance, Depression, Hypersensitivity reactions, Bronchospasm, Blood dyscrasias, Convulsions, Angioedema, Liver dysfunction, Incidence of sedation, Antimucarinic effects, Confusion.
Antihistamines (e.g T-Day 5mg Dihydrochloride) should be used with caution in prostatic hypertrophy, urinary retention, epilepsy, glaucoma, pyloroduodenal obstruction, hepatic disease. Caution may also be required in pregnancy and breast-feeding. Children and the elderly are more susceptible to side-effects.
High Risk Groups
Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/ she should reevaluate them and consult the reference material and previous studies